NYSE:BAXBaxter International Stock Price, Forecast & News

Baxter International's stock was trading at $77.97 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BAX shares have increased by 11.9% and is now trading at $87.21. View which stocks have been most impacted by Coronavirus.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 5 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Baxter International.

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, July 23rd 2020. View our earnings forecast for Baxter International.

Baxter International Inc (NYSE:BAX) announced its quarterly earnings data on Thursday, April, 30th. The medical instruments supplier reported $0.82 EPS for the quarter, topping the Zacks' consensus estimate of $0.73 by $0.09. The medical instruments supplier had revenue of $2.80 billion for the quarter, compared to the consensus estimate of $2.74 billion. Baxter International had a net margin of 8.85% and a return on equity of 22.70%. The company's quarterly revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.76 earnings per share. View Baxter International's earnings history.

Baxter International announced a quarterly dividend on Tuesday, May 5th. Stockholders of record on Friday, June 5th will be paid a dividend of $0.245 per share on Wednesday, July 1st. This represents a $0.98 annualized dividend and a dividend yield of 1.12%. The ex-dividend date of this dividend is Thursday, June 4th. This is an increase from Baxter International's previous quarterly dividend of $0.22. View Baxter International's dividend history.

Baxter International announced that its board has initiated a share repurchase plan on Tuesday, November 13th 2018, which authorizes the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to buy up to 6.1% of its stock through open market purchases. Stock buyback plans are often an indication that the company's board believes its stock is undervalued.

20 equities research analysts have issued 12 month price targets for Baxter International's shares. Their forecasts range from $84.00 to $105.00. On average, they expect Baxter International's stock price to reach $96.60 in the next twelve months. This suggests a possible upside of 10.8% from the stock's current price. View analysts' price targets for Baxter International.

Headlines about BAX stock have been trending negative this week, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Baxter International earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Baxter International.

Baxter International saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 4,030,000 shares, an increase of 31.3% from the June 15th total of 3,070,000 shares. Based on an average trading volume of 3,100,000 shares, the days-to-cover ratio is currently 1.3 days. Currently, 0.8% of the company's stock are short sold. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Steris (STE), Insulet (PODD) and Masimo (MASI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Honeywell International (HON), Cisco Systems (CSCO), AT&T (T), Pfizer (PFE), BlackRock (BLK), Verizon Communications (VZ), Abbott Laboratories (ABT) and Procter & Gamble (PG).

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International's stock is owned by a number of institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.03%), M&R Capital Management Inc. (0.00%) and Fulton Bank N. A. (0.00%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Sean Martin, Third Point Llc and Thomas T Stallkamp. View institutional ownership trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Fulton Bank N. A., and M&R Capital Management Inc.. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, and John D Forsyth. View insider buying and selling activity for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $87.21.

Baxter International has a market capitalization of $44.23 billion and generates $11.36 billion in revenue each year. The medical instruments supplier earns $1.00 billion in net income (profit) each year or $3.31 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.

The official website for Baxter International is www.baxter.com.

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]